Comparing PRP with Corticosteroids and Hyaluronic Acid (HA)

Clinical Outcomes, Corticosteroids, Hyaluronic Acid, Intra-articular Injections, Knee Osteoarthritis, PRP, Treatment Comparison

Background

Intra-articular injections commonly include corticosteroids, hyaluronic acid (viscosupplementation), or newer biologics including PRP. Understanding relative efficacy, durability, and safety is key to choosing among them.

Efficacy Comparisons

PRP vs HA

Meta-analyses and systematic reviews (2024–2025) consistently show PRP has superior outcomes in pain and function compared to HA, particularly in moderate-term (3–12 months) follow-up. SAGE Journals+4ScienceDirect+4MDPI+4
The “critical overview” reported many reviews find PRP outperforms HA, but cautioned the low methodological quality of many studies. SpringerLink
A 2024 meta-analysis found combination PRP + HA may further enhance effect versus PRP or HA alone. BioMed Central

PRP vs Corticosteroids (CS)

Corticosteroids provide rapid short-term pain relief, often peaking within weeks, but effects wane by ~6–8 weeks. PRP tends to have slower onset but more durable effect over 6–12 months. (Frontiers review) Frontiers
Trials show that while CS may outperform PRP in the first month, PRP overtakes CS at 3–6 months.
A systematic review with fragility index analysis of RCTs (Oeding et al., 2024) suggests many PRP vs alternative injection studies are statistically fragile, underscoring caution about overinterpretation. orthobullets.com

Safety & Side Effect Profiles

PRP and HA show similar safety profiles; both have mostly mild, local adverse effects (pain, swelling). No serious complications reported in trials. MDPI+2ScienceDirect+2
Corticosteroids carry potential risks: cartilage damage with repeated use, systemic steroid effects (glycemic impact), joint infection risk (though rare).
Long-term repeated CS injections are not advisable; PRP may offer safer long-range biologic support.

Durability & Repeatability

HA may need repeated courses every 6–12 months; its efficacy often plateaus.
PRP, when optimized, may reduce the need for frequent repeats, though “booster” injections are being studied.
CS is not typically repeated on short cycle due to deleterious effects with repetition.

Practical Guidance Based on Evidence

For rapid analgesia, short-term relief, a corticosteroid may be chosen initially; but for longer-term structural & symptomatic benefit, PRP seems superior beyond ~3 months.
Use HA in patients who cannot undergo biologics; PRP is more appealing for longer-lasting effect.
Combination strategies (PRP + HA) show early promise from meta-analysis (Zhang et al., 2024). BioMed Central
Always counsel patients that PRP has slower onset but potentially more durable benefit; some may need sequential or booster injections.

Conclusion

PRP tends to outperform HA and corticosteroids in medium-term outcomes, with better safety for longer use. The choice between them should consider onset vs durability, patient comorbidities, cost, and joint status.

Share the Post:

Relevant Articles

“Runner’s Trots”: The Real Medical Reason Endurance Athletes Sometimes Lose Bowel Control

What really happens when an elite athlete suddenly loses bowel control mid-race? The recent HYROX incident involving Australian athlete Joanna Wietrzyk put “runner’s trots” firmly in the spotlight — but exercise-induced diarrhoea, urgency and even faecal incontinence can happen to athletes at every level. During hard endurance exercise, blood is diverted away from the gut, repetitive impact can stimulate bowel activity, and heat, dehydration and pre-race nutrition can push the digestive system beyond its comfort zone. The result can be a sudden and sometimes very urgent need to go — with surprisingly little warning. So why does it happen, and can you prevent it? Here’s the real physiology behind one of endurance sport’s most awkward problems.

PRP for Knee Osteoarthritis: How Many Injections Do You Need, and How Long Does Relief Last?

If you're considering PRP for knee osteoarthritis, two of the biggest questions are how many injections are needed and how long the results may last. Recent research provides useful insight into both, with many clinical trials using a short course of 2–3 injections rather than a single treatment. Our latest evidence update looks at the durability of PRP, how platelet concentration may influence the length of benefit, and when a repeat course may be considered for patients who respond well.

Rotator Cuff Tendinopathy and PRP: Modest but Durable Benefit

Rotator cuff tendinopathy and partial-thickness tears are common causes of persistent shoulder pain, particularly when symptoms don't settle with rehabilitation alone. Research into PRP is growing, with recent trials suggesting its benefits may be modest but more durable over time compared with corticosteroid injections. Our latest evidence update explores the shoulder-specific research, including partial-thickness tears, injection technique and why precise targeting and a structured strengthening program remain important when considering PRP.